MarketCap
Facebook
X
TelegramQuarterly report 2023-Q1
added 05-05-2023
Heska Corporation Market Cap 2011-2025 | HSKA
As of December 24, 2025 Heska Corporation has a market cap of $ 1.31 B
Capitalization is the market value of a company whose shares are traded on the stock exchange. It is calculated by multiplying the market price of a share by the total number of the company's shares. Capitalization indicates volatility, risk, and growth potential. This metric is often used for a quick assessment of a company’s investment profile.[1]
Capitalization is an important indicator for investors and analysts, as it helps determine the size and significance of a company in the stock market. Companies with large capitalization are considered more stable and reliable, as they have more resources and financial power to grow and survive in the market.
This metric can be divided into several categories: small (from 300 million to 2 billion dollars), medium (from 2 to 10 billion dollars), and large (over 10 billion dollars). Companies with different levels of capitalization have their own characteristics and risks, so investors usually take this indicator into account when making investment decisions.
Capitalization can also change over time depending on the share price and the number of shares in circulation. Therefore, it is a dynamic indicator that requires constant monitoring and analysis to make well-informed investment decisions.
Annual Market Cap Heska Corporation
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 844 M | 1.83 B | 1.26 B | 759 M | 712 M | 553 M | 543 M | 243 M | 118 M | 49.7 M | 44.8 M | 39.7 M |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 1.83 B | 39.7 M | 583 M |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.
Market Cap of other stocks in the Diagnostics research industry
| Issuer | Market Cap | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
Brainsway Ltd.
BWAY
|
240 M | $ 19.51 | -0.61 % | $ 99.4 M |  Israel |
 |
Centogene N.V.
CNTG
|
221 M | - | -6.23 % | $ 30.6 M |  Germany |
|
Akumin
AKU
|
75.1 M | - | -17.87 % | $ 25.9 M |  Canada |
 |
DarioHealth Corp.
DRIO
|
43.4 M | $ 10.33 | 1.87 % | $ 293 M | Israel |
 |
DexCom
DXCM
|
48.8 B | $ 67.22 | 0.54 % | $ 25.9 B |  USA |
 |
Exact Sciences Corporation
EXAS
|
9.32 B | $ 101.52 | -0.07 % | $ 18.8 B | USA |
 |
Burning Rock Biotech Limited
BNR
|
2.95 B | $ 20.19 | -7.26 % | $ 217 M |  China |
 |
Accelerate Diagnostics
AXDX
|
40.3 M | - | -61.36 % | $ 2.46 M | USA |
 |
Biocept
BIOC
|
5.93 M | - | -13.05 % | $ 7.29 M | USA |
 |
BioNano Genomics
BNGO
|
3.55 M | $ 1.52 | -0.65 % | $ 1.93 M | USA |
 |
Oxford Immunotec Global PLC
OXFD
|
421 M | - | - | $ 562 M |  Britain |
 |
Castle Biosciences
CSTL
|
709 M | $ 39.92 | -0.7 % | $ 1.11 B | USA |
 |
Chembio Diagnostics
CEMI
|
12.6 M | - | 0.22 % | $ 16.8 M | USA |
 |
Danaher Corporation
DHR
|
152 B | $ 231.15 | 0.14 % | $ 169 B | USA |
 |
Mettler-Toledo International
MTD
|
29.9 B | $ 1 416.97 | 0.17 % | $ 30.1 B |  Schweiz |
 |
Fulgent Genetics
FLGT
|
467 M | $ 27.03 | -0.48 % | $ 817 M | USA |
 |
ENDRA Life Sciences
NDRA
|
2.2 M | $ 5.06 | -0.81 % | $ 2.72 M | USA |
 |
NeoGenomics
NEO
|
1.53 B | $ 12.23 | -1.57 % | $ 1.55 B | USA |
 |
Neogen Corporation
NEOG
|
1.02 B | $ 7.07 | -1.12 % | $ 1.53 B | USA |
 |
Global Cord Blood Corporation
CO
|
243 M | - | - | $ 399 M | China |
 |
Fluidigm Corporation
FLDM
|
481 M | - | 1.08 % | $ 308 M | USA |
 |
Genetic Technologies Limited
GENE
|
9.22 B | - | - | $ 7.1 B |  Australia |
 |
Genetron Holdings Limited
GTH
|
1.54 B | - | 0.12 % | $ 80.1 M | China |
 |
DermTech
DMTK
|
42.4 M | - | -11.32 % | $ 2.94 M | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
7.87 B | - | - | $ 10.7 B | USA |
 |
Pacific Biosciences of California
PACB
|
1.41 B | $ 1.86 | 1.92 % | $ 472 M | USA |
 |
Koninklijke Philips N.V.
PHG
|
30.8 B | $ 26.95 | 0.26 % | $ 20 B |  Niderland |
 |
CareDx, Inc
CDNA
|
521 M | $ 19.68 | -1.7 % | $ 1.06 B | USA |
 |
Celcuity
CELC
|
399 M | $ 101.8 | -0.54 % | $ 4.02 B | USA |
 |
Enzo Biochem
ENZ
|
57.5 K | - | -8.98 % | $ 14.8 K | USA |
 |
Precipio
PRPO
|
8.7 M | $ 23.89 | 2.56 % | $ 31 M | USA |
 |
Anixa Biosciences
ANIX
|
70.8 K | $ 3.38 | 2.42 % | $ 108 K | USA |
 |
Quidel Corporation
QDEL
|
10.6 B | $ 28.98 | 1.36 % | $ 1.22 B | USA |
 |
QIAGEN N.V.
QGEN
|
8.52 B | $ 45.7 | 0.2 % | $ 10.2 B | Niderland |
 |
Co-Diagnostics
CODX
|
34.9 M | $ 0.24 | -3.06 % | $ 7.04 M | USA |
 |
IQVIA Holdings
IQV
|
35.7 B | $ 225.46 | 0.14 % | $ 40.9 B | USA |
 |
Guardant Health
GH
|
5.84 B | $ 102.65 | 0.15 % | $ 12.6 B | USA |
 |
Sotera Health Company
SHC
|
3.48 B | $ 17.6 | 1.06 % | $ 4.98 B | USA |
 |
Aspira Women's Health
AWH
|
45.4 M | - | -6.19 % | $ 10.5 M | USA |
 |
Soleno Therapeutics
SLNO
|
1.96 B | $ 49.59 | 1.53 % | $ 1.99 B | USA |
 |
HTG Molecular Diagnostics
HTGM
|
2.99 M | - | -20.0 % | $ 1.06 M | USA |
 |
Trinity Biotech plc
TRIB
|
120 M | $ 1.11 | -13.24 % | $ 61.9 M |  Irlanda |
 |
Twist Bioscience Corporation
TWST
|
1.56 B | $ 33.17 | -1.98 % | $ 1.98 B | USA |
 |
Illumina
ILMN
|
16.4 B | $ 135.52 | -0.49 % | $ 21.5 B | USA |
 |
Charles River Laboratories International
CRL
|
8.54 B | $ 202.19 | -0.34 % | $ 10.4 B | USA |
 |
Quotient Limited
QTNT
|
183 M | - | -11.32 % | $ 1.1 M | Schweiz |
 |
Quest Diagnostics Incorporated
DGX
|
19.1 B | $ 175.91 | 0.47 % | $ 19.5 B | USA |
|
Biodesix
BDSX
|
92.1 M | $ 6.65 | -1.48 % | $ 862 M | USA |
 |
Myriad Genetics
MYGN
|
973 M | $ 6.5 | -0.99 % | $ 589 M | USA |